Community/Retail

A new online video announced today by the National Community Pharmacists Association illustrates the personal care that people receive at independent community pharmacies, the contributions of community pharmacists to better coordinated health care and how small business pharmacies support their local communities.

The FDA recently approved lifitegrast ophthalmic solution (Xiidra) to treat both the signs and symptoms of dry eye disease (DED) with an onset of action in as little as 2 weeks.

Mylan has launched a generic version of Merck's Temodar capsules, which may be used to treat patients with newly diagnosed cancerous tumors known as glioblastoma multiforme concomitantly with radiotherapy, then as maintenance treatment.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.